223 related articles for article (PubMed ID: 38578253)
1. An overview on recent patents and technologies on nanoparticles for nucleic acid delivery.
Dos Santos Fonseca LM; Machado BAS; Oliveira FO; de Jesus Santos JR; da Silva JW; Hodel KVS; Rosatti BG; Pinto CD; Soares MBP
Expert Opin Ther Pat; 2024 Mar; 34(3):171-186. PubMed ID: 38578253
[TBL] [Abstract][Full Text] [Related]
2. Non-viral nucleic acid containing nanoparticles as cancer therapeutics.
Kozielski KL; Rui Y; Green JJ
Expert Opin Drug Deliv; 2016 Oct; 13(10):1475-87. PubMed ID: 27248202
[TBL] [Abstract][Full Text] [Related]
3. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
Castillo RR; Baeza A; Vallet-Regí M
Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles: a review on recent perspectives and patents.
Paliwal R; Paliwal SR; Kenwat R; Kurmi BD; Sahu MK
Expert Opin Ther Pat; 2020 Mar; 30(3):179-194. PubMed ID: 32003260
[No Abstract] [Full Text] [Related]
5. Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.
Vaughan HJ; Green JJ; Tzeng SY
Adv Mater; 2020 Apr; 32(13):e1901081. PubMed ID: 31222852
[TBL] [Abstract][Full Text] [Related]
6. Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
Dobrovolskaia MA; McNeil SE
Expert Opin Drug Deliv; 2015 Jul; 12(7):1163-75. PubMed ID: 25994601
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
Li J; Wang Y; Zhu Y; Oupický D
J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
[TBL] [Abstract][Full Text] [Related]
8. Oral delivery of nucleic acid therapeutics: Challenges, strategies, and opportunities.
Jiang X; Wang N; Liu C; Zhuo Y; Liang L; Gan Y; Yu M
Drug Discov Today; 2023 Apr; 28(4):103507. PubMed ID: 36690175
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase supported design of carriers for therapeutic nucleic acid delivery.
Krhac Levacic A; Morys S; Wagner E
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28963371
[TBL] [Abstract][Full Text] [Related]
10. Towards safe nanoparticle technologies for nucleic acid therapeutics.
Miller AD
Tumori; 2008; 94(2):234-45. PubMed ID: 18564612
[TBL] [Abstract][Full Text] [Related]
11. Recent advancements in design of nucleic acid nanocarriers for controlled drug delivery.
Mosley RJ; Rucci B; Byrne ME
J Mater Chem B; 2023 Mar; 11(10):2078-2094. PubMed ID: 36806872
[TBL] [Abstract][Full Text] [Related]
12. Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.
Avila YI; Chandler M; Cedrone E; Newton HS; Richardson M; Xu J; Clogston JD; Liptrott NJ; Afonin KA; Dobrovolskaia MA
Molecules; 2021 Jan; 26(3):. PubMed ID: 33513786
[TBL] [Abstract][Full Text] [Related]
13. Advances in modification and delivery of nucleic acid drugs.
Wang J; Tan M; Wang Y; Liu X; Lin A
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):417-428. PubMed ID: 37643976
[TBL] [Abstract][Full Text] [Related]
14. Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery
Zhang T; Yin H; Li Y; Yang H; Ge K; Zhang J; Yuan Q; Dai X; Naeem A; Weng Y; Huang Y; Liang XJ
iScience; 2024 Jun; 27(6):109804. PubMed ID: 38770138
[TBL] [Abstract][Full Text] [Related]
15. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).
Ke W; Afonin KA
Adv Drug Deliv Rev; 2021 Sep; 176():113835. PubMed ID: 34144087
[TBL] [Abstract][Full Text] [Related]
16. Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.
Chen C; Yang Z; Tang X
Med Res Rev; 2018 May; 38(3):829-869. PubMed ID: 29315675
[TBL] [Abstract][Full Text] [Related]
17. Lipid Nanoparticles as Potential Gene Therapeutic Delivery Systems for Oral Administration.
Dorraj G; Carreras JJ; Nunez H; Abushammala I; Melero A
Curr Gene Ther; 2017; 17(2):89-104. PubMed ID: 28494737
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles for nucleic acid delivery: Current perspectives.
Samaridou E; Heyes J; Lutwyche P
Adv Drug Deliv Rev; 2020; 154-155():37-63. PubMed ID: 32526452
[TBL] [Abstract][Full Text] [Related]
19. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
20. Spherical Nucleic Acid Nanoparticles: Therapeutic Potential.
Kapadia CH; Melamed JR; Day ES
BioDrugs; 2018 Aug; 32(4):297-309. PubMed ID: 29959665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
